Cell-free DNA in the management of prostate cancer: Current status and future prospective

OBJECTIVE: With the escalating prevalence of prostate cancer (PCa) in China, there is an urgent demand for novel diagnostic and therapeutic approaches. Extensive investigations have been conducted on the clinical implementation of circulating free DNA (cfDNA) in PCa. This review aims to provide a co...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wei, Xiao, Yutian, Yan, Shi, Zhu, Yasheng, Ren, Shancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Military Medical University 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394290/
https://www.ncbi.nlm.nih.gov/pubmed/37538150
http://dx.doi.org/10.1016/j.ajur.2022.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394290/
https://www.ncbi.nlm.nih.gov/pubmed/37538150
http://dx.doi.org/10.1016/j.ajur.2022.11.002

Ejemplares similares